Source: Annual Congress 2012 - Sarcoidosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Bardaka, Z. Daniil, K. M. Antoniou, A. Mamara, F. Malli, K. I. Gourgoulianis, A. E. Germenis, M. Speletas (Larissa, Heraklion, Greece). Association study of ANXA11-R230C with sarcoidosis. Eur Respir J 2012; 40: Suppl. 56, 170

Member's Comments

No comment yet.

Related content which might interest you: Association of HLA variants with sarcoidosis in Korean population: pilot study Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Association of pulmonary and cardiac manifestations in patients with primary antiphospholipid syndrome: A review of the Serbian national cohort study Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Clinical phenotypes of extra-pulmonary sarcoidosis. The EpiSarc study Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype Year: 2018 Treatment of sarcoidosis: clinical guidelines of the Russian Respiratory Society Source: Virtual Congress 2021 – Russian programme 2021 Year: 2021 Treatment dilemmas in sarcoidosis - a retrospective cohort study Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Paediatric sarcoidosis Source: Eur Respir Monogr 2022; 96: 285-294 Year: 2022 The ICE study, Italian costs for exacerbations in COPD: a project of the Italian Association for COPD Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency Source: Eur Respir J, 50 (5) 1700610; 10.1183/13993003.00610-2017 Year: 2017 European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency Source: Guideline 2017 Year: 2017 Multicentric Latin American study of 211 patients with Interstitial lung disease and myositis related antibodies Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features Source: Eur Respir J 2015; 46: 976-987 Year: 2015 Risk factors for cardiac involvement in sarcoidosis - A case-control study in 201 Caucasian patients Source: International Congress 2016 – Sarcoidosis Year: 2016 European Respiratory Society Guidelines for the diagnosis and management of lymphangioleiomyomatosis (LAM) Source: Guideline 2010 Year: 2010 Association of TNF-α polymorphisms with COPD in a Spanish population Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 COPD classification according GOLD 2013 and Latin American Thoracic Association (ALAT) recommendations in PUMA study Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016 Genetic analysis of ethnicity of sarcoidosis patients in the Netherlands Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis Source: Eur Respir J 2010; 35: 14-26 Year: 2010 Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Management of severe asthma: summary of the European Respiratory Society/American Thoracic Society task force report Source: Breathe, 16 (2) 200058; 10.1183/20734735.0058-2020 Year: 2020